longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Shionogi

SGIOY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 9.36, below the reasonable range, cheaper than 87.8% of the time in the past 5 years, and the industry ranks 9/256, the industry Median -1.38.

9.36xP/E
$9.26Stock price
$0.99Earnings per share
9.36xP/E
Stock price$9.26Earnings per share$0.99

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
12.51x
Typical range
9.87x–15.75x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
9.46x5.72%$171.21B
SGIOYUSShionogi
9.36x--$15.76B
HYPMYUSHypera S.A.
9.43x--$3.10B
INVAUSInnoviva
4.29x32.30%$1.53B
APMDUSApnimed
5.28x114.94%$862.97M
CRMDUSCormedix
3.31x75.74%$614.98M
ORMPUSOramed Pharma
1.14x198.00%$197.59M
OGIUSOrganigram
2.35x510.33%$146.48M
SDEVUSStablecoin Development
0.16x--$79.47M
BTMDUSbiote Corp.
7.55x127.70%$44.19M
OWPCUSOne World Products, Inc.
0.04x--$142.42K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.